As a young and dynamic bio-venture founded in 2018, Future & Tech specializes in the research and development of human and veterinary drugs that leverage GRAS microbial cell surface target protein expression technology. The company aspires to become a global pharmaceutical provider as it pursues international technology licenses and regulatory approvals for specialized pharmaceutical products. With its headquarter and research center located in the Daejeon Technovalley, the company is actively engaged in the development of treatments for various muscle disorders, cancer cachexia, and diabetes. Future & Tech is currently preparing approvals for livestock enhancement products, while simultaneously working on human cancer cachexia and muscle disease treatments through projects supported by the Ministry of SMEs and Startups.
By clicking 'Accept all cookies', you agree to the storing of cookies on your device and to the associated processing of data to enhance site navigation, analyse site usage, and assist in our marketing and performance efforts.